Comparison of in‐field secondary cancer risk based on therapeutic proton dose between proton arc therapy and intensity‐modulated proton therapy in lung cancer patients
- DOI
- 10.1002/acm2.70793
- Published
- 2026-09
- Container
- Journal of Applied Clinical Medical Physics
- Publisher
- Wiley
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1002/acm2.70793,
title = {Comparison of in‐field secondary cancer risk based on therapeutic proton dose between proton arc therapy and intensity‐modulated proton therapy in lung cancer patients},
author = {Yuankang Xu and Wenguang Chen and Junxiang Wu and Hao Guo and Fanrui Zeng and Tianyu Zhang and Feng Yang and Xinhui Huang and Da Zhang and Xianliang Wang},
year = {2026},
journal = {Journal of Applied Clinical Medical Physics},
doi = {10.1002/acm2.70793},
url = {https://doi.org/10.1002/acm2.70793}
}RIS
TY - JOUR TI - Comparison of in‐field secondary cancer risk based on therapeutic proton dose between proton arc therapy and intensity‐modulated proton therapy in lung cancer patients AU - Yuankang Xu AU - Wenguang Chen AU - Junxiang Wu AU - Hao Guo AU - Fanrui Zeng AU - Tianyu Zhang AU - Feng Yang AU - Xinhui Huang AU - Da Zhang AU - Xianliang Wang PY - 2026 JO - Journal of Applied Clinical Medical Physics DO - 10.1002/acm2.70793 UR - https://doi.org/10.1002/acm2.70793 ER -
APA
Xu, Y., Chen, W., Wu, J., Guo, H., Zeng, F., Zhang, T., Yang, F., Huang, X., Zhang, D., & Wang, X. (2026). Comparison of in‐field secondary cancer risk based on therapeutic proton dose between proton arc therapy and intensity‐modulated proton therapy in lung cancer patients. Journal of Applied Clinical Medical Physics. https://doi.org/10.1002/acm2.70793
Source records
- crossref · retrieved 2026-09-25T04:10:43.923Z